High-dose gamma-globulin therapy for nephrotic membranous nephropathy patients
Not Applicable
- Conditions
- membranous nephropathy, nephrotic syndrome
- Registration Number
- JPRN-UMIN000006939
- Lead Sponsor
- Progressive Renal Diseases Research of the Ministry of Health, Labour and Welfare of Japan, research group of nephrotic syndrome and registry
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Secondary membranous nephropathy Diabetic patients Recent cardiovascular accidents within 6 months Malignancy Liver diseases Patients treated with immunosuppressive therapy
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method